150 related articles for article (PubMed ID: 11830479)
1. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.
Algara P; Mateo MS; Sanchez-Beato M; Mollejo M; Navas IC; Romero L; Solé F; Salido M; Florensa L; Martínez P; Campo E; Piris MA
Blood; 2002 Feb; 99(4):1299-304. PubMed ID: 11830479
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
[TBL] [Abstract][Full Text] [Related]
3. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
[TBL] [Abstract][Full Text] [Related]
4. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.
Traverse-Glehen A; Davi F; Ben Simon E; Callet-Bauchu E; Felman P; Baseggio L; Gazzo S; Thieblemont C; Charlot C; Coiffier B; Berger F; Salles G
Haematologica; 2005 Apr; 90(4):470-8. PubMed ID: 15820942
[TBL] [Abstract][Full Text] [Related]
5. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes.
Miranda RN; Cousar JB; Hammer RD; Collins RD; Vnencak-Jones CL
Hum Pathol; 1999 Mar; 30(3):306-12. PubMed ID: 10088550
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.
Camacho FI; Algara P; Rodríguez A; Ruíz-Ballesteros E; Mollejo M; Martínez N; Martínez-Climent JA; González M; Mateo M; Caleo A; Sánchez-Beato M; Menárguez J; García-Conde J; Solé F; Campo E; Piris MA
Blood; 2003 May; 101(10):4042-6. PubMed ID: 12511405
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments.
Perez M; Pacchiarotti A; Frontani M; Pescarmona E; Caprini E; Lombardo GA; Russo G; Faraggiana T
Br J Dermatol; 2010 Mar; 162(3):611-8. PubMed ID: 19906071
[TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene.
Mateo MS; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Leukemia; 2001 Apr; 15(4):628-34. PubMed ID: 11368366
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
[TBL] [Abstract][Full Text] [Related]
11. Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.
Tierens A; Delabie J; Malecka A; Wang J; Gruszka-Westwood A; Catovsky D; Matutes E
Am J Pathol; 2003 Feb; 162(2):681-9. PubMed ID: 12547726
[TBL] [Abstract][Full Text] [Related]
12. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
13. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.
Stamatopoulos K; Belessi C; Papadaki T; Kalagiakou E; Stavroyianni N; Douka V; Afendaki S; Saloum R; Parasi A; Anagnostou D; Laoutaris N; Fassas A; Anagnostopoulos A
Mol Med; 2004; 10(7-12):89-95. PubMed ID: 15706403
[TBL] [Abstract][Full Text] [Related]
15. Analysis of VH genes in 49 marginal zone lymphoma cases reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.
Dewolf Peeters C
Haematologica; 2005 Apr; 90(4):435. PubMed ID: 15820929
[No Abstract] [Full Text] [Related]
16. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
[TBL] [Abstract][Full Text] [Related]
17. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32.
Boonstra R; Bosga-Bouwer A; van Imhoff GW; Krause V; Palmer M; Coupland RW; Dabbagh L; van den Berg E; van den Berg A; Poppema S
Mod Pathol; 2003 Dec; 16(12):1210-7. PubMed ID: 14681321
[TBL] [Abstract][Full Text] [Related]
18. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F
Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978
[TBL] [Abstract][Full Text] [Related]
19. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
20. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
